Prenatal screens were notable for blood type B positive, antibody negative, RPR nonreactive, Rubella immune, hepatitis B surface antigen negative, and Group B Strep status unknown.
Mother was hospitalized and treated with magnesium sulfate and betamethasone.
On the day of delivery, she was found to have advanced dilation and was taken to cesarean section.
Respiratory: Baby boy [**Known lastname **] [**Name2 (NI) **] did require intubation and     received 2 doses of surfactant.
He was on a ventilator     until day of life 4 at which time he was able to     transition to CPAP.
On day of life 6, he was again     transitioned to nasal cannula oxygen and he remained in     nasal cannula until day of life 16.
His respiratory course was     also notable for an incidental finding of pulmonary     interstitial emphysema on chest [**Known lastname 37493**] on day of life 5.
Baby     boy [**Known lastname **] II was treated with caffeine for apnea of     prematurity from day of life 3-42.
This revealed a 3 mm patent ductus arteriosus which was     treated with 1 course of Indocin and was shown to be     closed on echocardiogram on day of life 5.
For     access, baby boy [**Name (NI) **] [**Name2 (NI) **] had an umbilical venous catheter     until day of life 5.
This was converted to a PICC line     which he had in place until day of life 20.
He has not     required IV access since that time.
He had a KUB at that time that was     normal and he was held NPO for 2 days.
His calories were then advanced     to a maximum of breast milk or Premature [**Name2 (NI) 37112**] 26     calories per ounce by day of life 23.
He has been treated with iron and vitamin E     supplementation from day of life 22 to the present.
His     vitamin E supplementation was discontinued on [**1-24**],     but he will be discharged on iron supplements.
He was     treated with ampicillin and gentamicin for a 48 hour rule     out and then antibiotics were discontinued as his blood     cultures were negative.
He was     treated with vancomycin and gentamicin for a 48 hour rule     out and then antibiotics were discontinued as cultures     were negative.
He has received immunization with hepatitis B vaccine on [**1-8**] and with Synagis on [**1-25**].
He is due for his 2 month immunizations on [**2-8**].
Synagis RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the following 3 criteria - i) born at less than 32 weeks; ii) born between 32 and 35 weeks with 2 of the following - day care during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities or school age siblings; or iii) with chronic lung disease.
Influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age.
Before this age (and for the first 24 months of the child's life), immunization against influenza is recommended for household contacts and out-of-home caregivers.
